Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC

Investegate announcements from AstraZeneca PLC, Saphnelo approved in EU for SLE

Related Keywords

Netherlands , Cambridge , Cambridgeshire , United Kingdom , United States , Amsterdam , Noord Holland , America , British , Ronald Van Vollenhoven , Astrazeneca Saphnelo , Al Sawah , Adrian Kemp , Centers For Disease , Medarex Inc , European Commission , American College Of Rheumatology , Nasdaq , Company On Twitter Astrazeneca , Astrazeneca , Amsterdam Rheumatology Center , Investor Relations Team , European Union , Lupus Foundation Of America , Medicinal Products , Human Use , European Medicines Agency , Executive Vice President , Japanand Canada , Bristol Myers Squibb , Uncontrolled Lupus , Interferon Pathway , Based Composite Lupus Assessment , New England Journal , Lancet Rheumatology , Rare Diseases , Disease Control , Systemic Lupus Erythematosus , Lupus Sci , Active Systemic Lupus , Receptor Monoclonal Antibody , Severe Systemic Lupus , Hopkins Lupus , Adult Patients , Lupus Foundation , Ann Rheum , Term Safety , Adult Subjects , Active Systemic Lupus Erythematosus , Arthritis Res , Typei Interferons , Basic Concepts , Clinical Relevance , Immune Mediated Inflammatory , Investegate Announcements , Investegate Company Announcements , Astrazeneca Plc , Egulatory News Service , Egulatory News Service And Regulatory , Ns ,